Professional Documents
Culture Documents
Dam Capital Initiating Coverage Report On JK Tyre Rating BUY Target
Dam Capital Initiating Coverage Report On JK Tyre Rating BUY Target
Dam Capital Initiating Coverage Report On JK Tyre Rating BUY Target
INITIATING COVERAGE
Steady improvement all around
BUY
JK Tyre Industries Ltd (JKI) is the flagship company of JK Organisation and is the
country’s third largest and globally among top 25 tyre makers. The company's
18 September 2023 product portfolio includes automotive tyres for two-wheelers (2W), three-wheelers
BSE Sensex: 67839 (3W), passenger cars, utility vehicles (UVs), trucks & buses and off-the-highway
(OHT) vehicles. Though, we expect a slowdown in the M&HCV industry in FY25E,
Sector: Automobiles
leading to lower OEM sales for the tyre industry, we expect replacement demand
to revive 2HFY24 onwards after a muted performance over the past 1.5 years and
expect a rebound in the exports markets hereon. JKI has been steadily gaining
share during the last 2-3 years. We believe that overall market share
Stock data improvement of 50-60bps over the last three years for JKI.
CMP (Rs) 259 With new product launches, better quality and brand equity improvement, the
Mkt Cap (Rs bn/USD m) 63.7 /766
company has witnessed better pricing and margins over the past three years. Its
consolidated EBITDA margins improved from pre-Covid 10.7% in FY19 to current
Target Price (Rs) 315 12.3% in Q1FY24. We expect pricing to remain largely stable, while volume growth
would be supported by better replacement demand and rebound in the exports.
Change in TP (%) NA
Its improved brand image, better margins, debt reduction-led better balance
Potential from CMP (%) 21.6 sheet position and controlled capex are key triggers for valuation expansion.
Therefore, we initiate coverage on JKI with a BUY rating and a target price of
Earnings change (%) Rs315. We value the stock at 10x FY25E, implying a 21.6% upside.
FY24E NA
Key Triggers:
FY25E NA
We expect the company to record a single-digit volume CAGR of ~7% and ASP
Bloomberg code JKI IN growth of 1.5% over FY23-FY25E, factoring in recovery in replacement and
export revival, while OEM growth would taper down to a low single-digit growth.
1-yr high/low (Rs) 286/142
JKI has gained some market shares in the PCR and 2W/3W segment over the
6-mth avg. daily volumes (m) 2.3 last 3 years on the back of capacity additions. We believe that its market share
gain to the tune of 20-30bps in PCR would aid volumes in FY24-25.
6-mth avg. daily traded value
JKI’s recent focus on premium categories with new launches in the PV
(Rsm/USDm) 486.1/5.8 segment, new products in various categories and foray into high-value EV
Shares outstanding (m) 246.2 segment would raise average realisation.
Free float (%) 43.7 Successful turn-around of the subsidiary in India and margin expansion in
Mexico would improve the consolidated financials.
Promoter holding (%) 56.3
Better margins, its steady deleveraging process, and improved brand equity,
are expected to expand valuation and lower the discounts to peers.
Price performance – relative & absolute
JK Tyre Sensex .
600 Key valuation metrics
to 31 Mar
Year FY21 FY22 FY23 FY24E FY25E
400 Net sales (Rs m) 90,431 1,18,529 1,46,449 1,58,813 1,74,328
Adj. net profit (Rs m) 2,950 2,077 3,025 6,605 8,166
200
Shares in issue (m) 246 246 246 246 260
Adj. EPS (Rs) 12.0 8.4 12.3 26.8 31.5
0
Sep-20 Jun-21 Mar-22 Dec-22 Sep-23
% change 34.6 (29.6) 45.6 118.3 17.3
(%) 3-mth 6-mth 1-yr PE (x) 9.1 13.9 12.6 9.6 8.2
JKI IN 36.1 73.6 38.4 Price/ Book (x) 1.0 1.0 1.2 1.6 1.4
EV/ EBITDA (x) 5.6 7.4 6.7 5.4 4.6
BSE Sensex 7.8 17.9 13.2
RoE (%) 11.3 7.3 9.7 18.4 18.5
RoCE (%) 11.9 8.5 10.5 17.3 19.0
Source: Company, DAM Capital Research
Mitul Shah
mitul@damcapital.in
42022643
For Private Circulation only “Important disclosures appear at the back of this report”
JK Tyre
We expect sizable net debt to reduction over the next two years due to lower capex
balance sheet improvement, requirements and healthy operational cash flow. Therefore, balance sheet
along with margin expansion, improvement, along with margin expansion, leads to valuation expansion and lower
leads to valuation expansion and discount to peers. We expect its valuation discount to peers (CEAT and Apollo Tyre)
lower discount to peers. We to fall to 20-25% from the historical 40%. Therefore, we assign 10x P/E to JKI on
expect its valuation discount to
FY25E earnings. In view of the strong products basket, healthy pricing, likely revival
peers (CEAT and Apollo Tyre) to
in replacement demand, better export potential, margin expansion in India as well
fall to 20-25% from the
as Mexico operations and valuation comfort at 8.2x FY25E, we have a positive view
historical 40%. Therefore, we
on JKI. Therefore, we initiate coverage on JKI with a BUY rating and a target price of
assign 10x P/E to JKI on FY25E
Rs315, valuing the stock at 10x FY25E EPS.
earnings....
20
9
15
6
10
3
5
0 0
Apr-11
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-17
Apr-18
Apr-19
Apr-20
Apr-21
Apr-22
Apr-23
Apr-11
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-17
Apr-18
Apr-19
Apr-20
Apr-21
Apr-22
Apr-23
Source: Bloomberg, DAM Capital Research Source: Bloomberg, DAM Capital Research
Investment Rationale
Stable Volume and Gradual Market Share Gain
We expect automobile production to record an 8% volume CAGR over FY23-FY25E, due to high base in the past two
years and a slower economic expansion. We expect similar volume growth for JKI in the OEM segment. The company
has gained market share in the PCR segment over the last 12-18 months. It is expected that market share level in
PCR will improve with better product positioning and further availability of capacity through expansions. JKI’s new
product launches and capacity expansion in PCR and TBR would help market share gain in the replacement segment.
However, export business still remains under pressure, which we expect to revive strongly H2FY24 onwards. Thus, we
expect stable volumes in the domestic OEM segment, strong revival in exports and marginal market share gain in the
replacement segment. Overall volume and revenues are expected to record 8% and 9% CAGR over FY23-FY25E. We
expect market share gain of 30-50 bps in the PCR segment on account of new capacity addition. Therefore, we
expect the overall volume CAGR of 7% over FY23-FY25E.
40.0%
20.0%
0.0%
-20.0%
FY20 FY21 FY22 FY23 FY24E FY25E
Source: Company, DAM Capital Research
Premiumisation and New Product Launches to Improve Pricing and Expand Margins
JKI has recently increased focus on new product launches with better quality, performance and premiumisation.
Contribution of high-margin premium products is steadily rising for both the operations. Brand equity of the company
has also improved in the last 2-3 years, supporting the pricing power. We believe that the new products, better quality
and network expansion would support market share gain in the replacement segment, going ahead. Moreover, its
improved exports traction from India as well as Mexico to major markets would provide a decent platform for the next
leg of growth. We expect the positive OEM trend to continue with ease owing to the supply of components and a
strong order book for PVs. The company’s PCR capacity expansion with a capex of Rs5.3bn is on track. Presently,
premiumisation in the PCR segment accounts for 25% of the overall PCR sales of JKI. The company aims to improve
this to 30% by FY24. In TBR, this stands at 85-90%, which was at 70% 3-4 years ago.
It has a state-of-the-art R&D centre in Mysore, Karnataka with more than 200 R&D and technology scientists and
engineers working in the field of advanced materials, alternate materials, nanotechnology, process and product
simulations, predictive technology, advanced tyre mechanics, etc.
JKI is also a pioneer in launching innovative products such as smart tyres, puncture guard tyres, ultra-high-
performance tyres and other premium products to differentiate itself in the marketplace and improve its market
share. We believe that this premiumisation trend, coupled with its foray into high-value EV segment, would drive
average realisation and margins of the company going forward.
Exhibit 6: EV Tyres
4000 2000
3000 1500
2000 1000
1000 500
0 0
-1000 -500
FY19 FY20 FY21 FY22 FY23 Q1FY24 FY19 FY20 FY21 FY22 FY23 Q1FY24
Source: Company, DAM Capital Research
JKI’s Mexico subsidiary JK Tornel’s revenues have grown significantly by 135% in last two years, with multi-fold
growth in the bottom line. As per management’s commentary in the recent earnings call, economic outlook in Mexico
is improving with higher-than-expected GDP, moderating inflation and low unemployment rate, supporting private
consumption and increased investment from companies relocating to the LATAM countries. Moreover, dealer stock
has also reduced significantly, hence dealer re-stocking would boost volumes ahead. The company has developed
new products for Mahindra Tractors USA, Polaris USA and has added new customers in USA, Brazil and Peru recently.
Margin Expansion and Debt Reduction Lowers Valuation Discounts and Re-rating Continues…
JKI’s net debt has reduced by ~25% since FY19 to Rs42.65bn as on 30 June 2023. The long-term borrowings are
expected to reduce further by 25% in next three years until FY26 (after considering term loan to be raised for the
ongoing PCR and TBR projects). The company has a clear focus to deleverage, with a target to bring down net D/E <
1x and net debt/EBITDA < 2x. Net debt to equity stood at 1.16x and net debt to EBIDTA stood at 2.44x as on 30 June
2023 ─ a significant improvement in last one year. JK Tornel’s net debt (primarily working capital) stood at Rs1.9bn
as on 30 June 2023 ─ there has been a sizable reduction since FY19 level of Rs5bn.
Therefore, we believe that margin expansion of 350bps over FY23-FY25E, debt reduction and comfortable D/E ratio,
in addition to improving return ratios, would lower its valuation discount to peers from 40% to 20%. Therefore, we
assign P/E valuation multiple of 10x to FY25E earnings.
Key Risks
Prolonged economic slowdown
Higher competitive intensity
Any major change in government regulation
Higher commodity prices or Sharp increase in crude prices
Adverse currency movement
Other Highlights:
In Q1FY24, capacity utilisation was at 85%.
The company won new orders from KIA and Hyundai.
Cavendish turned net positive.
The improvement in margins was a result of improvement in the subsidiary, operational performance and
commodity benefits.
The company plans to penetrate deeper into the domestic market and cover a wide range of distribution.
The company faced headwinds in the American continent on account of lower freight rates, influx of tyres from
Asian countries and appreciation of the Mexican pesos.
The economic outlook in Mexico is improving due to higher-than-expected GDP, moderating inflation, low
unemployment rate supporting private consumption and increase in investment from companies relocating to the
LATAM countries.
JK Tornel’s new potential customers are Mahindra Tractors USA, Polaris USA and Speed Max Brazil.
Cavendish Industries’ financial performance for Q1FY24: Revenue: Rs9.63bn, EBITDA: Rs1.21bn, EBITDA margin:
12.5% and PAT: Rs370mn.
The company is partnering with all the EV-Bus manufactures including Ashok Leyland, TATA Motors, JBM and
Olectra for the EV tyres.
North America is on the recovery path and is expected to recover by H2FY24.
JKI expects commercial vehicles to record nearly a double-digit growth and for passenger vehicles, it expects it to
be in a high single-digit.
The company has consumed MAT credit and will move into the new regime that will reduce its overall tax costs to
~30%.
Company Background:
JK Tyre Industries Ltd (JKI) is the flagship company of JK Organisation and is the country’s third largest and
globally among the top 25 tyre makers. The company's product portfolio includes automotive tyres for two-
wheelers (2W), three-wheelers (3W), passenger cars, utility vehicles (UVs), trucks & buses and off-the-highway (OHT)
vehicles. Over the years, it has gained ground in the exports market with new products. It is engaged in the
manufacturing of tyres, tubes and flaps with operation spread across seven manufacturing units in India. The
company has a stronger presence across markets, i.e., OEM (23%), replacement (60%) and exports (17%). JKI is
present in 105 countries with over 180 global distributors. The company has 12 globally benchmarked ‘sustainable’
manufacturing facilities ─ 9 in India and 3 in Mexico – that collectively produce ~35 mn tyres annually. The company
also has a strong network of over 4000 dealers and 500+ dedicated brand shops called Steel Wheels and Xpress
Wheels.
CV CV
56% 54%
PV PV
26% 28%
FY22 FY23
Exports
20% 17%
Replaceme
nt OEM Replacemen
54% 23% t
OEM
26% 60%
Revenue (Rs mn) Growth (%, RHS) EBITDA (Rs mn) EBITDA margin (%, RHS)
200,000 45.0% 24,000 20.0%
0 -15.0% 0 0.0%
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24E
FY25E
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24E
FY25E
Source: Company, DAM Capital Research Source: Company, DAM Capital Research
Exhibit 23: PAT trend Exhibit 24: EBITDA and ROCE trend
Net Profit (Rs mn) NPM (%, RHS) EBITDA (Rs mn) ROCE (%, RHS)
10,000 8.0% 25,000 15.0%
8,000 20,000 12.0%
6.0%
6,000 15,000 9.0%
4.0%
4,000 10,000 6.0%
2.0% 5,000 3.0%
2,000
0 0.0% 0 0.0%
FY23
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY24E
FY25E
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24E
FY25E
Source: Company, DAM Capital Research Source: Company, DAM Capital Research
Exhibit 25: PAT and ROE trend Exhibit 26: EPS Trend
PAT (Rs mn) ROE (%, RHS) EPS (Rs) Growth (%, RHS)
10,000 35.0% 40.0 2400%
8,000 28.0% 32.0 1800%
6,000 21.0% 24.0 1200%
4,000 14.0% 16.0 600%
2,000 7.0% 8.0 0%
0 0.0% 0.0 -600%
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24E
FY25E
FY21
FY15
FY16
FY17
FY18
FY19
FY20
FY22
FY23
FY24E
FY25E
Source: Company, DAM Capital Research Source: Company, DAM Capital Research
Glossary:
EV: Electric Vehicle
CV: Commercial Vehicle
HCV: Heavy Commercial Vehicle
LCV: Light Commercial Vehicle
PV: Passenger Vehicle
ICE: Internal Combustion Engine
BEV: Battery Electric Vehicle
2W: Two Wheeler
4W: Four Wheeler
PCR: Passenger Car Radial
TBR: Truck Bus Radial
TBB: Truck Bus Bias
STU: State Transports Undertaking
Disclaimer
This document has been prepared by DAM Capital Advisors Limited [the company/DAM Capital]. DAM Capital is a full-service, integrated investment
banking, and institutional broking company. DAM Capital is registered with SEBI as Research Analyst having SEBI Registration number as INH000000131.
Disclaimer/Disclosures:
The following disclosures are being made in Compliance with the SEBI Research Analyst Regulations 2014 (hereinafter referred to as Regulations)
1. DAM Capital the Research Entity (RE) is also engaged in the business of Investment Banking and Stock Broking and is registered with SEBI for the same.
2. There are no material disciplinary actions taken against DAM Capital as on the date of publication of this report.
3. DAM Capital and associates may from time to time solicit from or perform investment banking or other services for companies covered in its research
report. Hence, the recipient of this report shall be aware that DAM Capital may have a conflict of interest that may affect the objectivity of this report.
Investors should not consider this report as the only factor in making their investment decision.
4. The RE and/or its associate and/or the Research Analyst(s) may have financial interest or any other material conflict of interest in the company(ies)/
entities covered in this report. Please read this in conjunction with other disclosures herein.
5. The RE and/or its associate and/or the Research Analyst or relatives or family members of the Research Analyst may have actual/beneficial ownership
exceeding 1% or more of the securities of the company (ies) covered in this report as of the end of the month immediately preceding the date of
publication of the research report.
6. A. In the past 12 months period ending on the last day of the month preceding the date of publication of this research report, DAM Capital or any of its
associates may have:
Received any compensation for merchant banking, investment banking, stock broking or any other services from the Company covered by this
research report;
Managed or co-managed public offering of securities of the company covered by this research report
Received compensation for products and services other than investment banking, merchant banking or stock broking services.
B. DAM Capital or its associates have not received any compensation or any other benefits from the subject company or third party in connection with this
research report in the past 12 months period ending on the last day of the month preceding the date of publication of this research report.
7. The other disclosures/terms and conditions on which this research report is being published are as under:
i. This document is made for the sole use of clients or prospective clients of DAM Capital who are/proposed to be registered in India. It is not for sale to general
public.
ii. This document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or securities mentioned in this report or as an
official confirmation of any transaction. This document does not intend to provide any financial advice to buy/sell securities mentioned in this report.
iii. The information contained in this document has no regard to the specific investment objectives, financial situation or particular needs of any specific
recipient. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment
decision.
iv. The investment discussed or views expressed in the document may not be suitable for all investors. Investors should make their own investigations as
they deem necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including
the merits and risks involved) and investment decisions based upon their own financial objectives and financial resources.
v. The intent of this document is not recommendatory in nature.
vi. DAM Capital has not independently verified all the information given in this document. Accordingly, no representation or warranty, express or implied,
is made as to the accuracy, completeness or fairness of the information and opinions contained in this document.
vii. The Research Analyst and DAM Capital have not been engaged in market making activity for the company (ies) covered in the Research report.
viii. The information contained herein is from publicly available data or made by thorough analysis done by DAM Capital team. The views expressed are
those of analyst and the Company may or may not subscribe to all the views expressed therein.
ix. While DAM Capital would endeavour to update the information herein on reasonable basis, the opinions and information in this report are subject to
change without prior notice and prior approval and DAM Capital, its subsidiaries and associated companies, their directors and employees (“DAM
Capital and associates”) are under no obligation to update or keep the information current.
x. Subject to the disclosures made herein above, DAM Capital, its affiliates, their directors and the employees may from time to time, effect or have
effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to
perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of
these entities functions as a separate, distinct entity, independent of each other. The recipient shall take this into account before interpreting the
document.
xi. This material is being produced by DAM Capital solely for information purposes and for the use of the recipient. It is not to be reproduced,
redistributed or passed on directly or indirectly to any other person or published copied in whole or part for any purpose and the same shall be void
where prohibited.
xii. Neither the whole nor part of this document or copy thereof may be taken or transmitted into the United States of America “U.S. Persons” (except to
major US institutional investors (“MII”)) and Canada or distributed or redistributed, directly or indirectly, in the United States of America (except to
MII), Canada, Japan and China or to any resident thereof.
xiii. Where the report is distributed within the United States ("U.S.") it is being distributed pursuant to exemption under Rule 15a-6(a) (2), only to Major
U.S. Institutional Investors. The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this
document may come shall inform themselves about, and observe, any such restrictions.
xiv. In no circumstances DAM Capital, any of its directors, employees or any of its associates or any third party involved in, or related to, computing or
compiling the information have any liability for any damages of any kind including but not limited to any direct or consequential loss or damage,
however arising, from the use of this document.
Copyright of this document vests exclusively with DAM Capital Advisors Limited
Contd…
Disclaimer
Foreign currency-denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or the price of, or income derived
from, the investment. In addition, investors in securities, the values of which are influenced by foreign currencies effectively assume currency risk.
Associates of DAM Capital may have issued other reports that are inconsistent with and reach different conclusions from, the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country
or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject DAM Capital and its
associates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to a certain category of investors. Persons in whose possession this document may come are required to inform themselves of, and to observe,
such applicable restrictions.
Reports based on technical analysis centres on studying charts of a stock's price movement and trading volume, as opposed to focusing on a company's
fundamentals and, as such, may not match with a report on a company's fundamentals.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. DAM Capital will not treat recipients as
customers by virtue of their receiving this report.
The analyst certifies that all of the views expressed in this research report accurately reflect his/her personal views about any and all of the subject issuer(s)
or securities. The analyst certifies that no part of his / her compensation was, is, or will be directly or indirectly related to the specific recommendation(s)
and/or views expressed in this report.
ANALYST DISCLOSURES
1. The analyst(s) declares that neither he/she or his/her relatives have a Beneficial or Actual ownership of > 1% of equity of Subject Company/ companies;
2. The analyst(s) declares that he/she has no material conflict of interest with the Subject Company/ companies of this report;
3. The research analyst (or analysts) certifies that the views expressed in the research report accurately reflect such research analyst's personal views about
the subject securities and issuers; and
4. The research analyst (or analysts) certifies that no part of his or her compensation was, is, or will be directly or indirectly related to the specific
recommendations or views contained in the research report.
5. The research analyst declares that he has not served as an officer, director or employee of the subject company.
Rating System
Copyright in this document vests exclusively with DAM Capital Advisors Limited.
SEBI Registration Nos. of DAM Capital Advisors Limited
Research Analyst INH 000000 131
Stock Broker
NSE Capital Markets
NSE Futures & Options
INZ000207137
BSE Capital Markets
BSE Futures & Options
Merchant Banker INM000011336
www.damcapital.in
18 | For
DAM anyCAPITAL
assistance in access, please contact research@damcapital.in 18 September 2023